Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Pregnancy, puerperium and perinatal conditions

  • 93 clinical trials
  • 52 recruiting
  • 63 conditions
  • 25 countries

Conditions in this area

63 conditions with trials, the busiest first

Central nervous system lymphoma10Bronchopulmonary dysplasia9Pre-eclampsia8Cerebral palsy5Retinopathy of prematurity5Foetal growth restriction4Infantile apnoea4Neonatal respiratory distress syndrome4Netherton's syndrome4Neonatal alloimmune thrombocytopenia3Perineal injury3Premature baby3Abortion threatened2Diffuse large B-cell lymphoma2Gestational diabetes2Habitual abortion2Hypoxic ischaemic encephalopathy neonatal2Induced labour2Neonatal respiratory failure2Noonan syndrome2Perinatal depression2Placenta praevia2Pregnancy2Premature rupture of membranes2+39

Clinical trials in Pregnancy, puerperium and perinatal conditions

93 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

93 clinical trials

Central nervous system lymphoma

Recruiting

Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Deciphera Pharmaceuticals Inc.

Bronchopulmonary dysplasia

Recruiting

Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Retinol Palmitate
  • Sponsor:Aspire Pharma Limited

Cerebral palsy

Recruiting

Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

Investigational
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Neonatal respiratory distress syndrome

Recruiting

Comparing 1-Minute and 5-Minute Poractant Alfa Treatment for Respiratory Distress Syndrome in Very Premature Babies Born Before 28 Weeks

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Poractant Alfa
  • Sponsor:Medical University Of Graz

Infantile apnoea

Recruiting

Testing Caffeine Citrate for Reducing Breathing Support Needs in Premature Newborns with Primary Apnea

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Caffeine Citrate
  • Sponsor:Masarykova Univerzita

Netherton's syndrome

Recruiting

A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Sponsor:Biocryst Pharmaceuticals Inc.

Abortion spontaneous

Recruiting

Comparing hysteroscopic surgery to mifepristone and misoprostol treatment for early pregnancy loss in women under 10 weeks of pregnancy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Mifepristone
  • Sponsor:UZ Brussel

Bronchopulmonary dysplasia+1

Recruiting

A study on azithromycin for preventing airway infections in children aged 0-72 months with structural lung damage or congenital lung and airway malformations

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Azithromycin
  • Sponsor:Region Hovedstaden

Central nervous system lymphoma

Recruiting

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Antiphospholipid syndrome

Recruiting

Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Anifrolumab
  • Sponsor:National And Kapodistrian University Of Athens

Pre-eclampsia

Recruiting

Study on Pravastatin for Pregnant Patients with Preeclampsia or Intrauterine Growth Restriction

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pravastatin Sodium
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Reversible cerebral vasoconstriction syndrome

Recruiting

Study on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine
  • Sponsor:HUS Helsinki University Hospital

Substances studied in this area

The therapies tested most often in Pregnancy, puerperium and perinatal conditions trials.

Rituximab7 clinical trialsAcetylsalicylic Acid5 clinical trialsMethotrexate4 clinical trialsMisoprostol4 clinical trialsAmoxicillin3 clinical trialsDinoprostone3 clinical trialsMetformin Hydrochloride3 clinical trialsMifepristone3 clinical trialsNipocalimab3 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.